1. Home
  2. KRRO vs WALD Comparison

KRRO vs WALD Comparison

Compare KRRO & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$11.21

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Logo Waldencast plc

WALD

Waldencast plc

HOLD

Current Price

$1.68

Market Cap

179.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRRO
WALD
Founded
2014
1988
Country
United States
United Kingdom
Employees
N/A
364
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
150.0M
179.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
KRRO
WALD
Price
$11.21
$1.68
Analyst Decision
Buy
Strong Buy
Analyst Count
12
3
Target Price
$34.80
$2.00
AVG Volume (30 Days)
122.0K
624.0K
Earning Date
05-13-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,392,000.00
N/A
Revenue This Year
N/A
$9.89
Revenue Next Year
N/A
$4.31
P/E Ratio
N/A
N/A
Revenue Growth
181.46
N/A
52 Week Low
$5.20
$0.72
52 Week High
$55.89
$3.22

Technical Indicators

Market Signals
Indicator
KRRO
WALD
Relative Strength Index (RSI) 46.11 58.90
Support Level $10.81 $1.50
Resistance Level $14.42 $2.00
Average True Range (ATR) 0.99 0.18
MACD -0.07 0.02
Stochastic Oscillator 42.92 62.03

Price Performance

Historical Comparison
KRRO
WALD

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

About WALD Waldencast plc

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

Share on Social Networks: